Fig. 4From: Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenograftsH&E staining of four representative tumors (magnification ×5). a RT112luc xenograft from a vehicle-treated mouse. b RT112luc xenograft from a dasatinib (20 mg/kg BW twice daily)-treated mouse. c RT112rGEMCI20luc xenograft from a vehicle-treated mouse. d RT112rGEMCI20luc xenograft from a dasatinib (20 mg/kg BW twice daily)-treated mouseBack to article page